Lotus Pharmaceutical Co., Ltd. (TPE:1795)

Taiwan · Delayed Price · Currency is TWD

292.50

-32.00 (-9.86%)

At close: Feb 11, 2026

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals Segment	18.47B	16.86B	14.50B	12.53B	10.54B
Pharmaceuticals Segment Growth	9.52%	16.28%	15.78%	18.81%	10.45%
Others	333.96M	339.39M	301.39M	236.11M	258.72M
Others Growth	-1.60%	12.61%	27.65%	-8.74%	7.12%
Elimination	-218.95M	-245.38M	-171.32M	-112.78M	-72.90M
Total	18.58B	16.96B	14.63B	12.65B	10.73B
Total Growth	9.59%	15.89%	15.68%	17.90%	11.63%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	7.77B	6.81B	5.92B	4.45B	3.23B
United States Growth	13.98%	15.18%	32.95%	37.87%	20.13%
South Korea	5.71B	5.59B	5.28B	5.25B	5.11B
South Korea Growth	2.25%	5.86%	0.51%	2.83%	1.32%
Taiwan	2.52B	2.41B	1.44B	-	-
Taiwan Growth	4.28%	67.67%	-	-	-
Others	2.59B	2.14B	2.00B	2.95B	2.40B
Others Growth	20.74%	7.18%	-32.17%	23.12%	126.19%
Total	18.58B	16.96B	14.63B	12.65B	10.73B
Total Growth	9.59%	15.89%	15.68%	17.90%	11.63%

Source: S&P Global Market Intelligence.